Intended for healthcare professionals
INFLAMMATORY SKIN DISEASES

Inflammatory skin diseases: dermatological treatments for psoriasis

Susanne Farwer

MD is the Medical Solutions Lead for Dermatology in the UK and Ireland at UCB

Susanne Farwer talks about how the therapeutic agents of the past decade are revolutionising dermatological treatments and improving the quality of life of patients with psoriasis.

  • What have been the most significant advancements in dermatology and psoriasis management over the past decade?
  • What are the challenges and barriers that still exist and prevent patients from reaching their treatment goals?
  • How can the goal of reducing the time from diagnosis to effective treatment be achieved?
  • How will new technology such as machine learning and AI influence the dermatology space in the coming years?
  • What further advancements are needed in the dermatology space to achieve better health outcomes for patients, and enable an improved patient experience?

DOWNLOAD THE PDF TO READ THE FULL INTERVIEW

Dermatology in practice 2022; 28(1): 15–16
To continue reading this article, please sign in or register.

Dermatology in practice was previously supported by Wyeth from 2008 to 2010, by Wyeth and Serono in 2007, by Wyeth and Shire from 2005 to 2006, by Medlock Medical in 2004 and by SSL International from 2001 to 2003.

The data, opinions and statements appearing in the articles herein are those of the contributor(s) concerned; they are not necessarily endorsed by the publisher, Editor or Editorial Board. Accordingly the publisher, Editor and Editorial Board and their respective employees, officers and agents accept no liability for the consequences of any such inaccurate or misleading data, opinion or statement.

The title Dermatology in practice is the property of Hayward Medical Publishing and PMGroup Worldwide Ltd and, together with the content, is bound by copyright. Copyright © 2021 PMGroup Worldwide Ltd. All rights reserved. The information contained on the site may not be reproduced, distributed or published, in whole or in part, in any form without the permission of the publishers. All correspondence should be addressed to:

ISSN 0262-5504 (Print) ISSN 2049-8446 (Online)